Nikem Drugs Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2002.
2002 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Nikem Drugs Private Limited

Nikem Drugs Private Limited, a active private limited company, was established on 30 December 2002 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP2002PTC015469. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Employing 7 professional, Its leadership includes Rajesh Gangwani (Director), Geeta Gangwani (Director). It holds ₹3.16 Cr open charges and ₹4.95 M settled loans. Its latest AGM occurred on 30 November 2024, with the balance sheet filed on 31 March 2024. It is based at 245, Sector-F, Industrial Area, Sanwer Road,, Indore, Madhya Pradesh, 452010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP2002PTC015469

  • Registration Number

    015469

  • Incorporation Date

    30 December 2002

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 23 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.16 Cr
  • Satisfied Charges ₹ 4.95 M
  • Revenue Growth **** -6.51%
  • Profit Growth **** -25.90%
  • Ebitda **** -4.83%
  • Net Worth 17.87%
  • Total Assets -23.68%
Company report

Nikem Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Nikem Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nikem Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Gangwani Director 30 Dec 2002 Current
Geeta Gangwani Director 30 Dec 2002 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nikem Drugs.

Nikem Drugs Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 6.51% decrease. The company also saw a substantial fall in profitability, with a 25.9% decrease in profit. The company's net worth Soared by an impressive increase of 17.87%.

Nikem Drugs revenue growth over time
Nikem Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -6.51%
*******
*******
*******
*******
Revenue from Operations
*******
 -6.79%
*******
*******
*******
*******
Total Assets
*******
 -23.68%
*******
*******
*******
*******
Profit or Loss
*******
 -25.90%
*******
*******
*******
*******
Net Worth
*******
 17.87%
*******
*******
*******
*******
EBITDA
*******
 -4.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nikem Drugs?

Unlock access to Nikem Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹31,600,000.00

Satisfied Charges

₹4,950,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 3.02 Cr
  • State Bank Of Saurashtra : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
23 Aug 2024 Hdfc Bank Limited ₹0.65 M Open
26 Sep 2017 Hdfc Bank Limited ₹1.60 Cr Open
11 Sep 2017 Hdfc Bank Limited ₹1.35 Cr Open
10 Sep 2003 State Bank Of Saurashtra ₹1.45 M Open
03 Apr 2006 Union Bank Of India ₹4.95 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nikem Drugs?

Nikem Drugs has a workforce of 7 employees as of Mar 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nikem Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nikem Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nikem Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Nikem Drugs Private Limited last Annual general meeting of members was held on 30 Nov 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.65 M with Charge ID 101006952 was registered on 23 Aug 2024. was documented.

  • Balance Sheet

    The activity Nikem Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 16.00 M registered on 26 Sep 2017 with Charge ID 100142064 was modified on 05 Nov 2022. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 13.50 M registered on 11 Sep 2017 with Charge ID 100128171 was modified on 09 Feb 2022. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 16.00 M with Charge ID 100142064 was registered on 26 Sep 2017. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nikem Drugs Private Limited?

The CIN of Nikem Drugs Private Limited is U24232MP2002PTC015469.

Where is Nikem Drugs Private Limited headquartered?

Nikem Drugs Private Limited is headquartered at 245, Sector-F, Industrial Area, Sanwer Road,, Indore, Madhya Pradesh, 452010.

When was Nikem Drugs Private Limited incorporated?

Nikem Drugs Private Limited was incorporated on 30 December 2002.

Who are the current directors of Nikem Drugs Private Limited?

The current directors of Nikem Drugs Private Limited are

What is the primary industry of Nikem Drugs Private Limited?

The primary industry of Nikem Drugs Private Limited is Manufacturing.

Is Nikem Drugs Private Limited a listed company?

Nikem Drugs Private Limited is unlisted.

What is the capital structure of Nikem Drugs Private Limited?

The authorized capital of Nikem Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Nikem Drugs Private Limited?

The compliance status of Nikem Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available